Issue 1/2006

Suppression of glucosylceramide synthase by RNA interference reverses multidrug resistance in human breast cancer cells (1 — 8)

Y.-L., SUN, G.-Y., ZHOU, K.-N., LI, P., GAO, Q.-H., ZHANG, J.-H., ZHEN, Y.-H., BAI, X.-F., ZHANG,

Prognostic significance of tyrosinase mRNA detected by nested RT-PCR in patients with malignant melanoma (9 — 14)

N., GLUMAC, M., SNOJ, M., HOCEVAR, S., NOVAKOVIC,

Silencing of DMBT1 in neuroblastoma cell lines is not due to methylation of CCWGG motifs on its promoter (15 — 18)

J. MUNOZ, J.S. CASTRESANA

Current trends and perspectives in nutrition and cancer prevention (19 — 25)

I., BARTA, P., SMERAK, Z., POLIVKOVA, H., SESTAKOVA, M., LANGOVA, B., TUREK, J., BARTOVA,

The significance of soluble CD138 in diagnosis of monoclonal gammopathies (26 — 29)

V., MAISNAR, M., TOUSKOVA, M., TICHY, J., KREJSEK, L., CHROBAK, J., VOGLOVA, J., MALY,

The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer – single institution retrospective analysis (30 — 36)

H.-W., LEE, J.-H., CHOI, H.-Y., LIM, J.S., PARK, H.C., KIM, S., KANG, Y.T., OH, M., CHUN, S.S., SHEEN, Y.J., OH, K.J., PARK, S. C., HWANG

The relevance of the corticographic median nerve somatosensory evoked potentials (SEPs) phase reversal in the surgical treatment of brain tumors in central cortex (37 — 42)

R., TOMAS, P., HANINEC, L., HOUSTAVA,

P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients (43 — 48)

W., FAMULSKI, M., SULKOWSKA, A., WINCEWICZ, B., KEDRA, K., PAWLAK, B., ZALEWSKI, S., SULKOWSKI, M., KODA, M., BALTAZIAK,

HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia (49 — 55)

P., ZUBOR, A., VOJVODOVA, J., DANKO, K., KAJO, N., SZUNYOGH, Z., LASABOVA, K., BIRINGER, J., VISNOVSKY, K., DOKUS, P., GALAJDA, L., PLANK,

Reorganization of actin in K-562 and HL-60 cells treated with taxol (56 — 61)

A., GRZANKA, D., GRZANKA, A., ZURYN, A.A., GRZANKA, B., SAFIEJKO-MROCZKA,

Echocardiographic evaluation of early and chronic cardiotoxicity in adult patients treated for Hodgkin’s disease with ABVD regimen (62 — 66)

L. ELBL, I. VASOVA, Z. KRAL, M. NAVRATIL, L. SMARDOVA, J. VORLICEK

Risk of malignant tumors in first-degree relatives of patients with differentiated thyroid cancer – a hospital based study (67 — 72)

D., HANDKIEWCZ-JUNAK, T., BANASIK, Z., KOLOSZA, J., ROSKOSZ, A., KUKULSKA, Z., PUCH, B., JARZAB,

Comparison of NAT1, NAT2 & GSTT2-2 activities in normal and neoplastic human breast tissues (73 — 78)

Y.S., (GEYLAN) SU, B., ISGOR, T., COBAN, N., KAPUCUOGLU, S., AYDINTUG, M., ISCAN, M., ISCAN, T., GURAY,

Some biological actions of PEG-conjugated RNase A oligomers (79 — 85)

P., POUCKOVA, J., SKVOR, G., GOTTE, F., VOTTARIELLO, J.T., SLAVIK, J., MATOUSEK, D.V., LAURENTS, M., LIBONATI, J., SOUCEK,

Stem cell plasticity and carcinogenesis (87 — 91)

S., FILIP, J., MOKRY, D., ENGLISH,

Surfing on prothymosin alpha proliferation and anti-apoptotic properties (92 — 96)

K.P., LETSAS, M., FRANGOU-LAZARIDIS,

Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families (97 — 102)

S., CIERNIKOVA, M., TOMKA, M., KOVAC, V., STEVURKOVA, V., ZAJAC,

Analysis of the relationship between socioeconomic factors and stomach cancer incidence in Slovenia (103 — 110)

V., ZADNIK, B.J., REICH,

A disconnect between antitumor and antiangiogenic effects of fluvastatin in vitro and in vivo (111 — 118)

H., KLEMENT, J., RAK,

Raltitrexed plus oxaliplatin in the second-line treatment of metastatic colorectal cancer (119 — 127)

R., VYZULA, I., KOCAKOVA, R., R. DEMLOVA, I., KISS, L., DUSEK, J., JARKOVSKY,

Expression of MDR proteins in breast cancer and its correlation with some clinical and pathological parameters (128 — 135)

S., RYBAROVA, I., HODOROVA, M., HAJDUKOVA, K., SCHMIDTOVA, J., MOJZIS, K., KAJO, Z., KVIATKOVSKA, L., PLANK, M., BENICKY, A., MIROSSAY, E., BIROS, N., BOBROV

Myelodysplastic syndromes according to FAB and WHO classification. Single center experience (136 — 143)

O., HAUS, S., KOTLAREK-HAUS, S., POTOCZEK, M., CZARNECKA, E., DUSZENKO, I., MAKOWSKA, N., MIROWSKA, K., KULICZKOWSKI,

The regulation of human adrenomedullin (AM) and tumor necrosis factor alpha (TNF-alpha) receptors on human epithelial carcinoma (HeLa) cells. The role of AM secretion in tumor cell sensitivity (144 — 149)

D., DRIMAL, J., DRIMAL, J., DRIMAL JR,

Amplification of AML1 gene in association with karyotype, age and diagnosis in acute leukemia patients (150 — 154)

G., KIRSCHNEROVA, A., TOTHOVA, O., BABUSIKOVA,

Phenotypic quantitative features of patients with acute myeloid leukemia (155 — 160)

F.G., PEREIRA, K., METZE, F.P.S., COSTA, C.S.P., LIMA, I., LORAND-METZE,

Prostate-specific antigen value as a marker in breast cancer (161 — 167)

D., NARITA, A.M., CIMPEAN, A., ANGHEL, M., RAICA,

Resistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis (168 — 173)

J., STYCZYNSKI,, A., KOLTAN, M., WYSOCKI,

Cardiac function and cardiopulmonary performance in patients after treatment for non-Hodgkin's lymphoma. (174 — 181)

ELBL L, VASOVA I, TOMASKOVA I, JEDLICKA F, NAVRATIL M, POSPISIL Z, VORLICEK J

Cardiac troponins - biochemical markers of cardiac toxicity after cytostatic therapy. (183 — 190)

URBANOVA D, URBAN L, CARTER A, MAASOVA D, MLADOSIEVICOVA B

Garlic-derived organosulfides induce cytotoxicity, apoptosis, cell cycle arrest and oxidative stress in human colon carcinoma cell lines (191 — 199)

J., JAKUBIKOVA, J., SEDLAK,

Effect of IL-18 on leukocyte expression of iNOS and phospho-I kB in patients with squamous cell carcinoma of the oral cavity (200 — 205)

E., JABLONSKA, W., PUZEWSKA, M., CHARKIEWICZ,

Knockdown of survivin gene by vector-based short hairpin RNA technique induces apoptosis and growth inhibition in Burkitt's lymphoma Raji cell line. (206 — 212)

GU CM, ZHU YK, MA YH, ZHANG M, LIAO B, WU HY, LIN HL

Prognostic significance of plasma cell propidium iodide and annexin-V indices and their mutual ratio in multiple myeloma. (213 — 218)

SCUDLA V, ORDELTOVA M, MINARIK J, DUSEK L, ZEMANOVA M, BACOVSKY J

Induction of drug resistance in embryonal rhabdomyosarcoma treated with conventional chemotherapy is associated with HLA class I increase. (226 — 231)

PRADOS J, MELGUIZO C, FERNANDEZ JE, CARRILLO E, MARCHAL JA, BOULAIZ H, MARTINEZ A, RODRIGUEZ-SERRANO F, ARANEGA A

High dose rate brachytherapy in the treatment of oral cancer - the preliminary one institution experience. (232 — 236)

PETERA J, DOLEZEL M, JIROUSEK Z, TUCEK L, BEDROSOVA J, FRGALA T

Performance of opportunistic breast cancer screening in Slovenia. (237 — 241)

HERTL K, PRIMIC-ZAKELJ M, ZGAJNAR J, KOCIJANCIC I

Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer. (242 — 246)

MAZUREK A, KUC P, TERLIKOWSKI S, LAUDANSKI T

A correlation of microvascular density and proliferative activity to clinical and histological characteristics in neuroblastoma. (247 — 252)

DROZYNSKA E, IZYCKA-SWIESZEWSKA E, NIEDZWIECKI M, BALCERSKA A, PEREK D, WACHOWIAK J

Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma. (253 — 258)

WROBEL T, POREBA M, MAZUR G, POREBA R, PYSZEL A, BECK B, STEINMETZ-BECK A, ANDRZEJAK R, KULICZKOWSKI K

Expression and prognostic significance of Cathepsin L in early cutaneous malignant melanoma. (259 — 262)

STABUC B, MREVLJE Z, MARKOVIC J, STABUC-SILIH M

Preoperative radiotherapy for locally advanced rectal cancer and prognostic factors influencing outcome. (263 — 268)

PRAUSOVA J, LOHYNSKA R, KUBACKOVA K, LINKE Z, MALINOVA B, KUBALA E, NOVOTNY J JR

Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia (269 — 276)

K., ZAVODNA, M., BUJALKOVA, T., KRIVULCIK, A., ALEMAYEHU, M., SKORVAGA, G., MARRA, I., FRIDRICHOVA, J., JIRICNY, Z., BARTOSOVA,

International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy. (277 — 284)

SCUDLA V, ZEMANOVA M, MINARIK J, BACOVSKY J, ORDELTOVA M, INDRAK K, BUDIKOVA M, DUSEK L, FARBIAKOVA V

Role of circulating cytokeratin fragments and angiogenic factors in NSCLC patients stage IIIa-IIIb receiving curatively intended treatment. (285 — 290)

ERIKSSON P, BRATTSTROM D, HESSELIUS P, LARSSON A, BERGSTROM S, EKMAN S, GOIKE H, WAGENIUS G, BRODIN O, BERGQVIST M

Cytotoxic/antiproliferative effects of new [1,2,4]triazolo[4,3-c] quinazolines in tumor cell lines HeLa and B16 (291 — 300)

S., JANTOVA, S., LETASIOVA, R., OVADEKOVA, M., MUCKOVA,

Low expression of costimulatory molecules and mRNA for cytokines are important mechanisms of immunosuppression in acute lymphoblastic leukemia in children? (301 — 304)

W., LUCZYNSKI, A., STASIAK-BARMUTA, E., ILENDO, O., KOVALCHUK, M., KRAWCZUK-RYBAK, I., MALINOWSKA, M., MITURA-LESIUK, L., CHYCZEWSKI, M., MATYSIAK, J., KOWALCZYK, R., JAWOROWSKI,

Low frequency of the CHEK2*1100delC mutation among breast cancer probands from three regions of Poland (305 — 308)

E., KWIATKOWSKA, E., SKASKO, A., NIWINSKA, A., WOJCIECHOWSKA-LACKA, J., RACHTAN, L., MOLONG, D., NOWAKOWSKA, B., KONOPKA, A., JANIEC-JANKOWSKA, Z., PASZKO, J., STEFFEN,

Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer (309 — 315)

A., SHARMA, A., MISHRA, B. C., DAS, S., SARDANA, J. K., SHARMA,

Mutagenic and carcinogenic potential of menadione. (316 — 323)

COJOCEL C, NOVOTNY L, VACHALKOVA A

Adrenal incidentalomas and the metabolic syndrome – are there any differences between adenoma and hyperplasia? (324 — 327)

I., LAZUROVA, D., DUDASOVA, H., WAGNEROVA, I., DRAVECKA, D., PETRASOVA,

Ultraviolet radiation (UV) induces reorganization of actin cytoskeleton in CHOAA8 cells. (328 — 332)

GRZANKA D, DOMANIEWSKI J, GRZANKA A, ZURYN A

Chemoimmunotherapy with low dose vinorelbine and interleukin-2 in treatment of patients with metastatic renal cell carcinoma (333 — 336)

M. P., MENCOBONI, S., TREDICI, M., VARALDO, G., QUEIROLO, F., DURAND, L., REBELLA, V., GALBUSERA, I. M., PANNACCIULLI, R., GHIO,

Electrochemical behavior and determination of tumor inhibiting or promoting activities of flavonoids (337 — 342)

K., KOZICS, Z., KRAJCOVICOVA, A., VACHALKOVA,

Evaluation of serum and urine clusterin as a potential tumor marker for urinary bladder cancer (343 — 346)

D., STEJSKAL, R. R., FIALA,

Predictive value of relative changes in serum total sialic acid level for response to neoadjuvant chemotherapy in patients with locally advanced breast carcinoma (347 — 351)

O., CELEN, E., YILDIRIM, N., OZEN, C., SONMEZ,

Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene (353 — 362)

A., PASTORAKOVA, K., HLUBINOVA, J., JAKUBIKOVA, C., ALTANER,

Assay design and optimization of mutant-enriched PCR based method for detection of K-ras gene mutations in pancreatic carcinoma. (363 — 371)

UGORCAKOVA J, HLAVATY T, BABAL P, JANEGA P, BUKOVSKA G, HALGASOVA N, HLAVATA A, TIMKO J, DURIS I

Significance of tenascin-C, fibronectin, laminin, collagen IV, alpha5beta1 and alpha9beta1 integrins and fibrotic capsule formation around liver metastases originating from cancers of the digestive tract (372 — 383)

M.V., GULUBOVA, T.I., VLAYKOVA,

Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells (384 — 392)

J., DURAJ, J., BODO, M., SULIKOVA, P., RAUKO, J., SEDLAK,

Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer (393 — 401)

K., BOUCHALOVA, R., TROJANEC, Z., KOLAR, K., CWIERTKA, I., CERNAKOVA, V., MIHAL, M., HAJDUCH,

Mung bean sprout (Phaseolus aureus) nuclease and its biological and antitumor effects (402 — 409)

J., SOUCEK, J., SKVOR, P., POUCKOVA, J., MATOUSEK, T., SLAVIK, J., MATOUSEK,

Acute toxicity of conformal high dose interstitial brachytherapy boost in prostate cancer. (410 — 417)

SOUMAROVA R, HOMOLA L, STURSA M, PERKOVA H

In vivo fluorescence diagnostics and photodynamic therapy of gastrointestinal superficial polyps with aminolevulinic acid. A clinical and spectroscopic study (418 — 423)

J., SMOLKA, A., MATEASIK, B., CUNDERLIKOVA, L., SANISLO, P., MLKVY,

Immunogold detection of CD3 and CD4 antigens in patients with Mycosis fungoides (424 — 427)

A.A., GRZANKA, W., PLACEK, A., GRZANKA,

Anticancer effects of various Iranian native medicinal plants on human tumor cell lines (428 — 433)

Z., AMIRGHOFRAN, M., BAHMANI, A., AZADMEHR, K., JAVIDNIA,

Carboxymethyl chitin-glucan enriched diet exhibits protective effects against oxidative DNA damage induced in freshly isolated rat cells (434 — 439)

M., LAZAROVA, J., LABAJ, G., KOGAN, D., SLAMENOVA,

Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy (440 — 443)

L., KOZLOWSKI, T., FILIPOWSKI, M., RUCINSKA, W., PEPINSKI, J., JANICA, M., SKAWRONSKA, J., POZNANSKI, M.Z., WOJTUKIEWICZ,

Radioimmunoscintigraphy of colorectal carcinomas with three different radiopharmaceuticals (444 — 449)

V., OBRADOVIC, V., ARTIKO, M., PETROVIC, Ž., LAUSEVIC, M., STOJKOVIC, N., PETROVIC, D., SOBIC-SARANOVIC, M., VLAJKOVIC, Z., KRIVOKAPIC,

Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax (450 — 456)

S.Y., KANG, Y.T., OH, J.H., HAN, J.-H., CHOI, H.-Y., LIM, H.I., KIM, H.-W., LEE, J.H., JANG, J.S., PARK, H.C., KIM, S., KANG, M., CHUN

Reovirus – possible therapy of cancer (457 — 462)

K. FIGOVA, J. HRABETA, T. ECKSCHLAGER

Isothiocyanate iberin modulates phase II enzymes, posttranslational modification of histones and inhibits growth of Caco-2 cells by inducing apoptosis (463 — 470)

J. JAKUBIKOVA, Y. BAO, J. BODO1, J. SEDLAK

Effect of proteasome inhibitors on expression of HLA-G isoforms (471 — 477)

K. POLAKOVA, E. BANDZUCHOVA, M. BYSTRICKA, H. PANCUCHAROVA, G. RUSS

Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene (478 — 484)

A. PASTORAKOVA, K. HLUBINOVA, C. ALTANER

Reduction of DNA-damaging effects of anti-HIV drug 3’-azido-3’-dideoxythymidine on human cells by ursolic acid and lignin biopolymer (485 — 491)

D. SLAMENOVA, E. HORVATHOVA, M. BARTKOVA, Z. KRAJCOVICOVA, J. LABAJ, B. KOSIKOVA, I. MASTEROVA

International Staging System required standardization of biochemical laboratory testing in multiple myeloma (492 — 494)

M. TICHY, V. MAISNAR, V. PALICKA, B. FRIEDECKY, J. VAVROVA, H. NOVOTNA, Z. CERMAKOVA,M. DASTYCH, P. CECHAK, D. VOGTOVA, E. JAROLIMKOVA, H. BENAKOVA, L. HACHOVA, D. BEZDICKOVA, F. KOURIL, E.A. ZABRANSKA, J. ZENKOVA, P. SLABY, V. SCUDLA, E. GREGORA, I. SPICKA, J. STRAUB, M. SCHUTZOVA, R. HAJEK

Hormone-producing serous cystadenoma of the pancreas (495 — 499)

J. RABCZYNSKI, H. MILNEROWICZ, M. SLIWINSKA-MOSSON, M. JABLONOWSKA, S. MILNERIWICZ, W. KNAST, M. ZABEL

The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia (500 — 506)

T. ZELEZNIKOVA, O. BABUSIKOVA

Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary? (507 — 510)

R. YERUSHALMI, A. SULKES, M. MISHAELI, A. NEUMANN, M. DINERMAN, J. SULKES, S. RIZEL, N.YAROM, H.GUTMAN, E. FENIG

Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI (511 — 517)

A.CS. NAGY, E. TOLNAY, T. NAGYKÁLNAI, T. FORSTER

Constitutive NF-kappaB activity in colorectal cancer cells: impact on radiation-induced NF-kappaB activity, radiosensitivity, and apoptosis (518 — 523)

R. VOBORIL, J. WEBEROVA-VOBORILOVA

Natural microbial polysaccharide sulphoethyl glucan as antigenotoxic and cancer preventing agent (524 — 529)

V. VLCKOVA, S. NADOVA, V. DUHOVA, K. ZAVODNA, Z. MORANOVA, P. RAUKO, G. KOGAN, E. MIADOKOVA

Transfection of nm23-H1 increased expression of -Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981 (530 — 537)

G. CHE, J. CHEN, L. LIU, Y. WANG, L. LI, Y. QIN, Q. ZHOU

Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells (538 — 543)

H.C. SILVA, F. GARCAO, E.C. COUTINHO, C.F. DE OLIVEIRA, F.J. REGATEIRO